Deutsche Bank AG Increases Stake in Axon Enterprise, Inc $AXON

Deutsche Bank AG increased its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 10.5% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 407,432 shares of the biotechnology company’s stock after purchasing an additional 38,781 shares during the period. Deutsche Bank AG’s holdings in Axon Enterprise were worth $228,410,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently bought and sold shares of the company. Darwin Wealth Management LLC acquired a new position in Axon Enterprise during the 2nd quarter valued at approximately $37,000. Creative Financial Designs Inc. ADV purchased a new position in shares of Axon Enterprise in the fourth quarter worth $28,000. Camelot Portfolios LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $30,000. AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $34,000. Finally, Strive Financial Group LLC acquired a new stake in shares of Axon Enterprise during the fourth quarter worth $41,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on AXON. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Piper Sandler raised their target price on Axon Enterprise from $724.00 to $732.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Citizens Jmp reaffirmed a “market outperform” rating and set a $700.00 price target on shares of Axon Enterprise in a research report on Thursday, June 25th. Barclays boosted their price target on Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a report on Thursday, May 7th. Thirteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $730.92.

Insiders Place Their Bets

In related news, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $400.00, for a total transaction of $800,000.00. Following the sale, the insider directly owned 52,813 shares of the company’s stock, valued at $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the transaction, the insider owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This represents a 4.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 68,989 shares of company stock worth $36,016,932. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Trading Up 2.6%

Shares of Axon Enterprise stock opened at $619.85 on Wednesday. The stock has a market cap of $50.36 billion, a PE ratio of 257.20, a price-to-earnings-growth ratio of 9.95 and a beta of 1.39. The firm has a fifty day moving average price of $532.07 and a 200 day moving average price of $473.93. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $794.29. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating the consensus estimate of $1.84 by $0.04. The company had revenue of $904.39 million for the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The firm’s revenue was up 35.3% on a year-over-year basis. During the same period in the prior year, the company earned $2.12 earnings per share. Equities research analysts predict that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.